CD200 is overexpressed in a wide variety of solid and hematological tumor cell types, including chronic lymphocytic leukemia (CLL) multiple myeloma (MM), acute myeloid leukemia (AML) and others, and is also expressed at elevated levels on cancer stem cells [14–18]. The gene discussed is CD200; the disease is acute myeloid leukemia.